Rocuronium Bromide Injection
Product Images NDC 25021-687

6 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 25021-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Roc08 0001 01)

Structural Formula (Roc08 0001 01)
Chemical structure diagram of Rocuronium Bromide showing its molecular arrangement including a steroid backbone, quaternary ammonium group, and bromide ion.*
FDA Label Image

Figure 1 (Roc08 0001 02)

Figure 1 (Roc08 0001 02)
A box plot chart showing time in minutes on the vertical axis against Rocuronium Bromide dosage in mg/kg on the horizontal axis for three age groups: 18-64 years, 65 years and older, and 1-12 years. The chart visualizes the distribution of response times across different doses and age ranges.*
FDA Label Image

Figure 2 (Roc08 0001 03)

Figure 2 (Roc08 0001 03)
A scatter plot with overlaid box plots showing time in minutes on the vertical axis against various dosages in mg/kg on the horizontal axis. The data is grouped by age categories: 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. Each group includes multiple data points illustrating variability in time measurements.*
FDA Label Image

Figure 3 (Roc08 0001 04)

Figure 3 (Roc08 0001 04)
A line chart depicting the relationship between dose number (1 to 5) on the x-axis and time in minutes (0 to 30) on the y-axis. Two data series are plotted: one for 0.15 mg/kg with 13 subjects, showing an increase from about 15 to 20 minutes; and one for 0.1 mg/kg with 29 subjects, showing a steady time around 10 to 15 minutes.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Roc08 0001 05)

Package Label – Principal Display Panel – Vial Label (Roc08 0001 05)
Label for Rocuronium Bromide Injection 50 mg per 5 mL (10 mg per mL) by Sagent Pharmaceuticals. The label indicates it is a 5 mL multi-dose vial for intravenous use only, with a warning about its paralyzing effects and the necessity of immediate availability of artificial respiration. Storage and handling instructions, manufacturer information, lot, and expiration date spaces are also shown.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Roc08 0001 06)

Package Label – Principal Display Panel – Vial Label (Roc08 0001 06)
Label for Rocuronium Bromide Injection 100 mg per 10 mL (10 mg per mL) by Sagent Pharmaceuticals. It is a 10 mL multi-dose vial for intravenous use. The label includes warnings for paralyzing agent, storage instructions, manufacturer details (Sagent Pharmaceuticals, Schaumburg, IL), and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.